Prestige Consumer Healthcare (PBH) Non Operating Interest Expenses (2010 - 2024)

Prestige Consumer Healthcare has reported Non Operating Interest Expenses for 13 years, with the latest figure at $11.5 million in Q4 2024.

• On a quarterly basis, Non Operating Interest Expenses fell 30.89% year-over-year to $11.5 million in Q4 2024; TTM through Dec 2024 was $53.4 million, a 27.64% decrease from a year earlier, with the FY2023 full-year figure at $69.2 million, up 7.59% from the prior year.
• Non Operating Interest Expenses was $11.5 million for Q4 2024 at Prestige Consumer Healthcare, down from $12.3 million in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $22.1 million in Q1 2020, with the low at $11.5 million in Q4 2024.
• Average Non Operating Interest Expenses over 3 years is $16.6 million, with a median of $17.1 million recorded in 2023.
• The sharpest annual moves came in 2020 and 2024: Non Operating Interest Expenses slipped 12.36% in 2020, then slumped 30.89% in 2024.
• Over 3 years, Non Operating Interest Expenses stood at $22.0 million in 2020, then fell by 24.54% to $16.6 million in 2023, then plunged by 30.89% to $11.5 million in 2024.
• The last three Non Operating Interest Expenses figures came in at $11.5 million (Q4 2024), $12.3 million (Q3 2024), and $13.1 million (Q2 2024), per Business Quant data.